The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%< ...
The ambitious plans aim to secure medicine supply, accelerate innovation, strengthen clinical research, and reinforce IP ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...
80-year-old Tripat Singh from Chandigarh is winning the internet with his jaw-dropping fitness videos. Proving that age is ...
AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...
The EU executive is expected to push ahead with an extremely streamlined timeline for a key piece of health legislation, ...
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE ... Meloxicam is a COX-2 preferential non-steroidal anti-inflammatory drug (NSAID) and rizatriptan is a 5-HT 1B/1D agonist. SYMBRAVO is designed to provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback